These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31465841)

  • 41. Targetable long non-coding RNAs in cancer treatments.
    Chen L; Dzakah EE; Shan G
    Cancer Lett; 2018 Apr; 418():119-124. PubMed ID: 29341880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Androgen receptor and miR-206 regulation in prostate cancer.
    Chua FY; Adams BD
    Transcription; 2017; 8(5):313-327. PubMed ID: 28598253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer.
    Zhang X; Pang P; Jiang M; Cao Q; Li H; Xu Y; Li Y; Chen X; Han J
    Dis Markers; 2020; 2020():8847986. PubMed ID: 33029258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism.
    Shih JW; Wang LY; Hung CL; Kung HJ; Hsieh CL
    Int J Mol Sci; 2015 Dec; 16(12):28943-78. PubMed ID: 26690121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer.
    Xu N; Wu YP; Yin HB; Xue XY; Gou X
    J Transl Med; 2018 Oct; 16(1):274. PubMed ID: 30286759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.
    Sattari M; Kohvakka A; Moradi E; Rauhala H; Urhonen H; Isaacs WB; Nykter M; Murtola TJ; Tammela TLJ; Latonen L; Bova GS; Kesseli J; Visakorpi T
    Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37140987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
    Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
    Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer.
    Zhu YS; Zhu J
    Adv Clin Chem; 2022; 106():91-179. PubMed ID: 35152976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.
    Brisotto G; Guerrieri R; Colizzi F; Steffan A; Montico B; Fratta E
    Methods Mol Biol; 2021; 2292():73-94. PubMed ID: 33651353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative analysis reveals the dosage sensitivity and regulatory patterns of lncRNA in prostate cancer.
    Liu Y; Zhang R; Zhao N; Zhang Q; Yan Z; Chang Z; Wei Y; Wu C; Xu J; Xu Y
    Mol Biosyst; 2016 Oct; 12(10):3176-85. PubMed ID: 27507663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review).
    Fu M; Zou C; Pan L; Liang W; Qian H; Xu W; Jiang P; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1207-18. PubMed ID: 27431376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer.
    Lin Y; Tan H; Yu G; Zhan M; Xu B
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications.
    Zhang L; Meng X; Zhu XW; Yang DC; Chen R; Jiang Y; Xu T
    Mol Cancer; 2019 May; 18(1):102. PubMed ID: 31133028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
    Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM
    Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
    Nanni S; Bacci L; Aiello A; Re A; Salis C; Grassi C; Pontecorvi A; Gaetano C; Farsetti A
    Mol Cell Endocrinol; 2020 Jul; 511():110864. PubMed ID: 32413384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer.
    Zhang A; Zhao JC; Kim J; Fong KW; Yang YA; Chakravarti D; Mo YY; Yu J
    Cell Rep; 2015 Oct; 13(1):209-221. PubMed ID: 26411689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.